PD-1 Inhibitors-Related Neurological Toxicities in Patients with Non-Small-Cell Lung Cancer: A Literature Review

The advent of immune checkpoint inhibitors gave rise to a new era in oncology and general medicine. The increasing use of programmed death-1 (PD-1) inhibitors in non-small cell lung cancer and in other malignancies means clinicians have to face up to new challenges in managing immune-related adverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirabile, Aurora, Brioschi, Elena, Ducceschi, Monika, Piva, Sheila, Lazzari, Chiara, Bulotta, Alessandra, Viganò, Maria Grazia, Petrella, Giovanna, Gianni, Luca, Gregorc, Vanesa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468526/
https://www.ncbi.nlm.nih.gov/pubmed/30832285
http://dx.doi.org/10.3390/cancers11030296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468526/
https://www.ncbi.nlm.nih.gov/pubmed/30832285
http://dx.doi.org/10.3390/cancers11030296

Ejemplares similares